相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis, evaluation, molecular dynamics simulation and targets identification of novel pyrazole-containing imide derivatives
Wenxi Cai et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Synthesis, structural, molecular docking and spectroscopic studies of (E)-N'-(4-methoxybenzylidene)-5-methyl-1H-pyrazole-3-carbohydrazide
Khalid Karrouchi et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment
Nina J. Wesdorp et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study
Fateme Azimi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Synthesis, crystal structure, DFT, α-glucosidase and α-amylase inhibition and molecular docking studies of (E)- N′-(4-chlorobenzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide
Khalid Karrouchi et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates
Jeffrey Y. W. Mak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Synthesis, X-ray, spectroscopy, molecular docking and DFT calculations of (E)-N′-(2,4-dichlorobenzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide
Khalid Karrouchi et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Recent trends in cancer therapy: A review on the current state of gene delivery
Esam Bashir Yahya et al.
LIFE SCIENCES (2021)
Histone Deacetylase 7 Gene Overexpression Is Associated with Poor Prognosis of Triple-Negative Breast Cancer Patients
Bojana Uzelac et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2021)
The Relationship between Mycoplasmas and Cancer: Is It Fact or Fiction ? Narrative Review and Update on the Situation
Elhem Yacoub et al.
JOURNAL OF ONCOLOGY (2021)
Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis, in silico docking and in vitro cytotoxicity analysis
Monika Chaudhary et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies
Fariba Peytam et al.
MOLECULAR DIVERSITY (2020)
Molecular docking and dynamics studies on novel benzene sulfonamide substituted pyrazole-pyrazoline analogues as potent inhibitors of Plasmodium falciparum Histo aspartic protease
Mahalakshmi Thillainayagam et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Histone deacetylase inhibitor pre-treatment enhances the efficacy of DNA-interacting chemotherapeutic drugs in gastric cancer
Ramchandra Vigay Amnekar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Overview of recent developments of pyrazole derivatives as an anticancer agent in different cell line
Fatima Ezzahra Bennani et al.
BIOORGANIC CHEMISTRY (2020)
Selected arylsulphonyl pyrazole derivatives as potential Chk1 kinase ligands-computational investigations
Kornelia Czaja et al.
JOURNAL OF MOLECULAR MODELING (2020)
Synthesis, X-ray structure, vibrational spectroscopy, DFT, biological evaluation and molecular docking studies of (E)-N'-(4-(dimethylamino)benzylidene)-5-methyl-1H-pyrazole-3-carbohydrazide
Khalid Karrouchi et al.
JOURNAL OF MOLECULAR STRUCTURE (2020)
Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors
Kirsten McAulay et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
New pyrazolopyrimidine derivatives with anticancer activity: Design, synthesis, PIM-1 inhibition, molecular docking study and molecular dynamics
John N. Philoppes et al.
BIOORGANIC CHEMISTRY (2020)
CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK
Binyan Lin et al.
ONCOGENE (2020)
Synthesis, Characterization, Free-radical Scavenging Capacity and Antioxidant Activity of Novel Series of Hydrazone, 1,3,4-oxadiazole and 1,2,4-triazole Derived from 3,5-dimethyl-1H-pyrazole
Khalid Karrouchi et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2019)
Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity
Nevine M. Y. Elsayed et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis, spectroscopic characterization, reactive properties by DFT calculations, molecular dynamics simulations and biological evaluation of Schiff bases tethered 1,2,4-triazole and pyrazole rings
Renjith Raveendran Pillai et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Discovery of novel pyrazole derivatives as potential anticancer agents in MCL
Fansheng Ran et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells
Valentina Cutano et al.
MOLECULAR ONCOLOGY (2019)
Anticancer properties of novel pyrazole-containing biguanide derivatives with activating the adenosine monophosphate-activated protein kinase signaling pathway
Sichun Zhou et al.
ARCHIV DER PHARMAZIE (2019)
New pyrazole derivatives: Synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES
Ghaneya S. Hassan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer
Kai Xiong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells
Corrado Caslini et al.
ONCOGENE (2019)
Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice
Villo Muha et al.
OPEN BIOLOGY (2019)
Enhanced carbonyl stress induces irreversible multimerization of CRMP2 in schizophrenia pathogenesis
Manabu Toyoshima et al.
LIFE SCIENCE ALLIANCE (2019)
Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives
Daipeng Xiao et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment
Parham Jabbarzadeh Kaboli et al.
PLOS ONE (2018)
Discovery of VEGFR2 inhibitors by integrating naive Bayesian classification, molecular docking and drug screening approaches
De Kang et al.
RSC ADVANCES (2018)
Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives
Eman S. Nossier et al.
MOLECULES (2018)
New Pyrazole-Hydrazone Derivatives: X-ray Analysis, Molecular Structure Investigation via Density Functional Theory (DFT) and Their High In-Situ Catecholase Activity
Khalid Karrouchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Investigation of acetylcholinesterase and mammalian DNA topoisomerases, carbonic anhydrase inhibition profiles, and cytotoxic activity of novel bis(-aminoalkyl)phosphinic acid derivatives against human breast cancer
Taner Dastan et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2017)
CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2
Jana Malikova et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Therapeutic Outlook of Pyrazole Analogs: A Mini Review
Swastika Ganguly et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
Yubin Lei et al.
MOLECULAR CANCER (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
The expression of HDAC7 in cancerous gastric tissues is positively associated with distant metastasis and poor patient prognosis
Y. Yu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Synthesis, characterization, anticancer, antimicrobial and carbonic anhydrase inhibition profiles of novel (3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl) phenyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione derivatives
Umit M. Kocyigit et al.
BIOORGANIC CHEMISTRY (2017)
The therapeutic voyage of pyrazole and its analogs: A review
Mohemmed Faraz Khan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Galeterone for the treatment of advanced prostate cancer: the evidence to date
Diogo A. Bastos et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence
Lei Jianyong et al.
ONCOTARGET (2016)
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Yixuan Li et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
CYP17 inhibitors in prostate cancer: latest evidence and clinical potential
Anitha B. Alex et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Inhibition of the VEGF/VEGFR Pathway Improves Survival in Advanced Kidney Cancer: A Systematic Review and Meta-Analysis
Roberto Iacovelli et al.
CURRENT DRUG TARGETS (2015)
Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: Synthesis and anticancer activity
Jing Bo Shi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
Fred Saad et al.
LANCET ONCOLOGY (2015)
Crystal structure of N′-diphenylmethylidene-5-methyl-1H-pyrazole-3-carbohydrazide
Khalid Karrouchi et al.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS (2015)
New CYP17 Hydroxylase Inhibitors: Synthesis, Biological Evaluation, QSAR, and Molecular Docking Study of New Pregnenolone Analogs
Najim A. Al-Masoudi et al.
ARCHIV DER PHARMAZIE (2014)
Orteronel for the treatment of prostate cancer
Kathryn Van Hook et al.
Future Oncology (2014)
Possible Prognostic and Therapeutic Significance of c-Kit Expression, Mast Cell Count and Microvessel Density in Renal Cell Carcinoma
Ilaria Marech et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Structures of Human Steroidogenic Cytochrome P450 17A1 with Substrates
Elyse M. Petrunak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
CYP17 inhibitors-abiraterone, C17,20-lyase inhibitors and multi-targeting agents
Lina Yin et al.
NATURE REVIEWS UROLOGY (2014)
C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma
Annette Zimpfer et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
Further Characterization of HDAC and SIRT Gene Expression Patterns in Pancreatic Cancer and Their Relation to Disease Outcome
Mehdi Ouaissi et al.
PLOS ONE (2014)
Collapsin response mediator protein 2 is involved in regulating breast cancer progression
Kazuhiro Shimada et al.
BREAST CANCER (2014)
The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
Shalome A. Bassett et al.
NUTRIENTS (2014)
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
M. Scartozzi et al.
BRITISH JOURNAL OF CANCER (2013)
Pyrazole scaffold: A remarkable tool in the development of anticancer agents
Harish Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera et al.
NATURE CHEMICAL BIOLOGY (2013)
Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients
Camillo Porta et al.
ONCOLOGY (2013)
Development and Clinical Utility of Abiraterone Acetate as an Androgen Synthesis Inhibitor
A. Bryce et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
Michele McTigue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Investigation of the Differences in Activity between Hydroxycycloalkyl N1 Substituted Pyrazole Derivatives As Inhibitors of B-Raf Kinase by Using Docking, Molecular Dynamics, QM/MM, and Fragment-Based De Novo Design: Study of Binding Mode of Diastereomer Compounds
Julio Caballero et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc
Caihua Zhu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
CYP17 inhibitors for prostate cancer therapy
Tadas S. Vasaitis et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Raf kinases in cancer-roles and therapeutic opportunities
G. Maurer et al.
ONCOGENE (2011)
Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
Daniel Antunes Moreno et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
In Silico Docking and Electrophysiological Characterization of Lacosamide Binding Sites on Collapsin Response Mediator Protein-2 Identifies a Pocket Important in Modulating Sodium Channel Slow Inactivation
Yuying Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field
Devleena Shivakumar et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2010)
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou et al.
NATURE (2010)
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer
Je Ang et al.
BRITISH JOURNAL OF CANCER (2009)
Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Sorafenib A Review of its Use in Advanced Hepatocellular Carcinoma
Gillian M. Keating et al.
DRUGS (2009)
Sunitinib in solid tumors
Hui K. Gan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Cytochrome P450 and chemical toxicology
F. Peter Guengerich
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells
Harriet M. Kluger et al.
LABORATORY INVESTIGATION (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The role of histone deacetylases (HDACs) in human cancer
Santiago Ropero et al.
MOLECULAR ONCOLOGY (2007)
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Paola Gallinari et al.
CELL RESEARCH (2007)
Raf: A strategic target for therapeutic development against cancer
M Beeram et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Class II histone deacetylases:: from sequence to function, regulation, and clinical implication
XJ Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas
ZH Lin et al.
MODERN PATHOLOGY (2004)
Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma
YH Hwang et al.
HEPATOLOGY RESEARCH (2004)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
